Legal and ethical considerations of artificial intelligence in skin cancer diagnosis
- PMID: 34407234
- DOI: 10.1111/ajd.13690
Legal and ethical considerations of artificial intelligence in skin cancer diagnosis
Abstract
Artificial intelligence (AI) technology is becoming increasingly accurate and prevalent for the diagnosis of skin cancers. Commercially available AI diagnostic software is entering markets across the world posing new legal and ethical challenges for both clinicians and software companies. Australia has the highest rates of skin cancer in the world and is poised to be a significant benefactor and pioneer of the technology. This review describes the legal and ethical considerations raised by the emergence of artificial intelligence in skin cancer diagnosis and proposes recommendations for best practice.
Keywords: apps; artificial intelligence; diagnosis; ethical; legal; skin cancer; smartphone.
© 2021 The Australasian College of Dermatologists.
References
-
- Hamet P, Tremblay J. Artificial intelligence in medicine. Metabolism 2017; 69: S36-40.
-
- Hosny A, Parmar C, Quackenbush J et al. Artificial intelligence in radiology. Nat. Rev. Cancer. 2018; 18: 500-10.
-
- Niazi MKK, Parwani AV, Gurcan MN. Digital pathology and artificial intelligence. Lancet Oncol. 2019; 20: e253-61.
-
- Du-Harpur X, Watt F, Luscombe N et al. What is AI? Applications of artificial intelligence to dermatology. Br. J. Dermatol. 2020; 183: 423-30.
-
- Scheetz J, He M, van Wijngaarden P. Ophthalmology and the emergence of artificial intelligence. Med. J. Aust. 2021; 214: 155.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
